Press and media

For press enquires please contact Helen on 020 74873892 or email [email protected] or call Sarah on 01923 779555 or email [email protected]

Latest

Follow-Up Study Suggests Potential Measure of Target Engagement

In this exciting study, Professor Tom Foltynie and colleagues have analysed 'exosomes' - small brain cell-derived sacks or 'vesicles' - in follow-up research from the recent Exenatide study and funded by CPT...
Lord-Lieutenant of Hertfordshire, Robert Voss CBE, becomes a Patron of The Cure Parkinson’s Trust

The Cure Parkinson's Trust announces The Lord-Lieutenant of Hertfordshire, Robert Voss CBE, as a new Patron
Fit4Change App

The Fit4Change app allows you to raise free funds for CPT as they donate 5p to CPT’s pioneering Parkinson’s research with every mile you run, walk or cycle.
Ceres Events 7th Annual Charity Raceday Luncehon

CPT is delighted to be a beneficiary charity of the Ceres Events 7th Annual Charity Raceday Luncheon being held on Wednesday 17th April at Cheltenham Racecourse.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut.
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed drugs

Our international Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Stem Cell Therapies - Research Updates

When diagnosed, people with Parkinson’s have often had the disease for years and have lost over half of the dopamine producing cells in their brain. Now scientists are searching for a way to replace these nerve cells.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more

The Annual Review 2018

Our Annual Review 2018 - your online publication here... Read more

Parkinson's Movement

The Science of Parkinson's - Dr Simon Stott

Leave a gift in your Will

A donation to The Cure Parkinson's Trust will make a huge difference to our research to slow, stop or even reverse Parkinson's. Read more